semaglutide vs tirzepatide mechanisms vs. Semaglutide: How to Choose? How diabetes medications like semaglutide

What This Means for Patients and the Future of GLP-1 Access Gallagher's success underscores AI's potential to lower barriers in metabolic health, making GLP-1 therapy more affordable

The GLP-1 Megatrend (1 of 4): The Mechanistic Blind Spot No One Wants to Admit Published in Biomedical Research India Ambler and 2 others The rapid ascent of GLP-1based therapies has created one of the most consequential shifts in modern medicine, reshaping clinical practice across obesity, diabetes, cardiometabolic disease, liver pathology, and even neurodegeneration

Given all these unknowns, it may be best for Congress to pump the brakes on expanding GLP-1s in Medicare before we have a better understanding of their full value and a way to pay for it.

Insufficient fiber, especially when gut motility is already slowed, significantly worsens constipation

A lot of these peptides that were on the okay to compound list, in late 2023, 2024, they took them off the list. Demand remained

And the Kidneys GLP-1s may also benefit kidney health